Core Insights - The "Healthy China" strategy emphasizes cancer prevention and patient care, with breast cancer being a major concern for women's health [1] - In 2022, China reported 357,200 new breast cancer cases, ranking second among common malignant tumors in women, with a mortality rate ranking fifth [1] - The five-year survival rate for breast cancer patients has improved to 83.2% due to early screening and innovative treatments, but it remains only 20% for late-stage patients [1] Project Launch - The "Healthy China共HER New Life" patient education project was officially launched in Nanjing, supported by the Beijing Aipu Cancer Patient Care Foundation and guided by the Chinese Society of Clinical Oncology (CSCO) [1][3] - The project aims to enhance breast cancer patients' understanding of their disease and treatment, thereby improving treatment adherence and quality of life [1][3] Expert Insights - Professor Yin Yongmei emphasized that patient knowledge significantly influences treatment adherence and prognosis, highlighting the importance of comprehensive care and support [5] - The CSCO patient education committee aims to create a patient-centered education ecosystem to improve disease understanding and empower patients [5] Future Activities - Over the next year, the project will organize diverse educational activities, including a patient education manual based on the new CSCO breast cancer treatment guidelines and expert video content [7] - The initiative will facilitate a shift from passive treatment to active disease management for breast cancer patients, promoting confidence in treatment options [7][8]